Cited by 566Diabetes and associated disordersGenetic Associations and EpidemiologyT-cell and B-cell Immunology

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

Etiology of Type 1 Diabetes

Open access

Todd, John A.·2010·Immunity

DOI 10.1016/j.immuni.2010.04.001

Open this paper in CoChat — free account Open PDF

Abstract

Recent genetic mapping and gene-phenotype studies have revealed the genetic architecture of type 1 diabetes. At least ten genes so far can be singled out as strong causal candidates. The known functions of these genes indicate the primary etiological pathways of this disease, including HLA class II and I molecules binding to preproinsulin peptides and T cell receptors, T and B cell activation, innate pathogen-viral responses, chemokine and cytokine signaling, and T regulatory and antigen-presenting cell functions. This review considers research in the field of type 1 diabetes toward identifying disease mechanisms using genetic approaches. The expression and functions of these pathways, and, therefore, disease susceptibility, will be influenced by epigenetic and environmental factors. Certain inherited immune phenotypes will be early precursors of type 1 diabetes and could be useful in future clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2010.04.001

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,723
Factors influencing the composition of the intestinal microbiota in early infancy
Penders, J., Thijs, C., Vink, C., Stelma, F. F., Snijders, B., Kummeling, I., van den Brandt, P. A., & Stobberingh, E. E. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2824 · Cited by 2,232
ChIP–seq: advantages and challenges of a maturing technology
Park, P. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2641 · Cited by 2,217
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Self-citation
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Self-citation
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D. P., Heath, S. C., Depner, M., Berg, A. V., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,590

Show all 120 references

Sorted by citations

Items 101–200 of 566

Integrated Enrichment Analysis of Variants and Pathways in Genome-Wide Association Studies Indicates Central Role for IL-2 Signaling Genes in Type 1 Diabetes, and Cytokine Signaling Genes in Crohn's Disease
Carbonetto, P. S., & Stephens, M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003770 · Cited by 68
Inflammation as death or life signal in diabetic fracture healing
Rőszer, T. (2010) · Inflammation Research · doi:10.1007/s00011-010-0246-9 · Cited by 67
FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children
Viisanen, T., Gazali, A. M., Ihantola, E., Ekman, I., Näntö‐Salonen, K., Veijola, R., Toppari, J., Knip, M., Ilonen, J., & Kinnunen, T. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00019 · Cited by 64
Stochastic Virtual Population of Subjects With Type 1 Diabetes for the Assessment of Closed-Loop Glucose Controllers
Haidar, A., Wilinska, M. E., Graveston, J. A., & Hovorka, R. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2272736 · Cited by 69
Early Detection of Peripheral Blood Cell Signature in Children Developing β-Cell Autoimmunity at a Young Age
Kallionpää, H., Somani, J., Tuomela, S., Ullah, U., de Albuquerque, R., Lönnberg, T., Komsi, E., Siljander, H., Honkanen, J. K., Härkönen, T., et al. (2019) · Diabetes · doi:10.2337/db19-0287 · Cited by 66
Blood-based signatures in type 1 diabetes
Cabrera, S. M., Chen, Y.-G., Hagopian, W., & Hessner, M. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3843-x · Cited by 63
Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes
Wen, X., & Yang, Y. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0232 · Cited by 62
A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes
Winkler, C., Krumsiek, J., Lempainen, J., Achenbach, P., Grallert, H., Giannopoulou, E., Bunk, M., Theis, F. J., Bonifacio, E., & Ziegler, A.-G. (2012) · Genes & Immunity · doi:10.1038/gene.2012.36 · Cited by 68
MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research
Juan‐Mateu, J., Villate, O., & Eizirik, D. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0916 · Cited by 59
Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
Beyan, H., Riese, H., Hawa, M. I., Beretta, G., Davidson, H. W., Hutton, J. C., Burger, H., Schlosser, M., Snieder, H., Boehm, B. O., et al. (2012) · Diabetes · doi:10.2337/db11-0971 · Cited by 60
The impact of epigenomics on future drug design and new therapies
Hamm, C. A., & Costa, F. F. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.007 · Cited by 59
High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease
Schweiger, D. Š., Mendez, A., Jamnik, S. K., Bratanič, N., Bratina, N., Battelino, T., Brecelj, J., & Vidan‐Jeras, B. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1164144 · Cited by 58
Epigenetic alterations in chronic disease focusing on Behçet’s disease: Review
Alipour, S., Nouri, M., Sakhinia, E., Samadi, N., Roshanravan, N., Ghavami, A., & Khabbazi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.106 · Cited by 60
Effects of Type 1 Diabetes-Associated IFIH1 Polymorphisms on MDA5 Function and Expression
Looney, B. M., Xia, C., CONCANNON, P. J., Ostrov, D. A., & Clare-Salzler, M. J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0656-8 · Cited by 58
Epigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 59
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment
Newby, B. N., & Mathews, C. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00232 · Cited by 57
Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
Raz, I., Ziegler, A. G., Linn, T., Schernthaner, G., Bonńici, F., Distiller, L. A., Giordano, C. S. D. S., Giorgino, F., de Vries, L., Mauricio, D., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1391 · Cited by 57
Retracted
Regulation of iNOS Gene Transcription by IL-1β and IFN-γ Requires a Coactivator Exchange Mechanism
Burke, S. J., Updegraff, B. L., Bellich, R. M., Goff, M. R., Lu, D., Minkin, S. C., Karlstad, M. D., & Collier, J. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1159 · Cited by 63
Redox regulation of m6A methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes
De Jesus, D. F., Zhang, Z., Brown, N. K., Li, X., Xiao, L., Hu, J., Gaffrey, M. J., Fogarty, G., Kahraman, S., Wei, J., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01368-0 · Cited by 56
Interleukin‐1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset
Cabrera, S. M., Wang, X., Chen, Y., Jia, S., Kaldunski, M. L., Greenbaum, C. J., the Type 1 Diabetes TrialNet Canakinumab Study Group, Mandrup-Poulsen, T. R., the AIDA Study Group, & Hessner, M. J. (2015) · European Journal of Immunology · doi:10.1002/eji.201546005 · Cited by 58
Infection as a cause of type 1 diabetes?
Christen, U., Bender, C., & von Herrath, M. G. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283533719 · Cited by 56
B cell-directed therapies in type 1 diabetes
Mariño, E., Silveira, P. A., Stolp, J., & Grey, S. T. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.006 · Cited by 56
Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
Thompson, W. S., Pękalski, M. Ł., Simons, H. Z., Smyth, D. J., Dopico, X. C., Guo, H., Guy, C., Dunger, D. B., Arif, S., Peakman, M., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12362 · Cited by 56
Self-citation
Position β57 of I-A g7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset
Gioia, L., Holt, M., Costanzo, A. E., Sharma, S. M., Abe, B. T., Kain, L., Nakayama, M., Wan, X., Su, A. I., Mathews, C. E., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6329 · Cited by 54
Type 1 diabetes and gut microbiota: Friend or foe?
Hu, C., Wong, F. S., & Li, W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.006 · Cited by 55
Temporal profiling of cytokine-induced genes in pancreatic β-cells by meta-analysis and network inference
Lopes, M., Kutlu, B., Miani, M., Bang‐Berthelsen, C. H., Størling, J., Pociot, F., Goodman, N., Hood, L., Welsh, N., Bontempi, G., et al. (2014) · Genomics · doi:10.1016/j.ygeno.2013.12.007 · Cited by 52
Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes
Saleh, N. M., Raj, S. M., Smyth, D. J., Wallace, C., Howson, J. M. M., Bell, L., Walker, N. M., Stevens, H. E., & Todd, J. A. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1259 · Cited by 51
Self-citation
Tc17 CD8+ T Cells Potentiate Th1-Mediated Autoimmune Diabetes in a Mouse Model
Saxena, A., Desbois, S., Carrié, N., Lawand, M., Mars, L. T., & Liblau, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103111 · Cited by 51
It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
Creusot, R. J., Giannoukakis, N., Trucco, M., Clare-Salzler, M. J., & Fathman, C. G. (2013) · Diabetes · doi:10.2337/db13-0886 · Cited by 51
Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
Fuchs, J., & Hovorka, R. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.679484 · Cited by 51
Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases
Koboziev, I., Jones‐Hall, Y., Valentine, J. F., Webb, C. R., Furr, K. L., & Grisham, M. B. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000446 · Cited by 50
Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats
Bejar, W., Hamden, K., Salah, R. B., & Chouayekh, H. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2013.08.006 · Cited by 49
A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study
Kozhakhmetova, A., Wyatt, R. C., Caygill, C. H., Williams, C. L., Long, A. E., Chandler, K. A., Aitken, R. J., Wenzlau, J. M., Davidson, H. W., Gillespie, K. M., et al. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13115 · Cited by 48
Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression
Xhonneux, L.-P., Knight, O., Lernmark, Å., Bonifacio, E. E., Hagopian, W., Rewers, M., She, J., Toppari, J., Parikh, H. M., Smith, K. G. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5666 · Cited by 48
Organ donor specimens: What can they tell us about type 1 diabetes?: Pancreas histopathology in type 1 diabetes
Campbell-Thompson, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12286 · Cited by 46
CRISPR-Cas9–Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes
Lin, X., Pelletier, S. W., Gingras, S., Rigaud, S., Maine, C. J., Marquardt, K., Dai, Y., Sauer, K., Rodriguez, A. R., Martin, G., et al. (2016) · Diabetes · doi:10.2337/db16-0061 · Cited by 46
Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function
Raugh, A., Allard, D., & Bettini, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911151 · Cited by 46
Deletion of 12/15-Lipoxygenase Alters Macrophage and Islet Function in NOD-Alox15null Mice, Leading to Protection against Type 1 Diabetes Development
Green-Mitchell, S. M., Tersey, S. A., Cole, B. K., Ma, K., Kuhn, N. S., Cunningham, T. D., Maybee, N. A., Chakrabarti, S. K., MCDUFFIE, M. J., Taylor, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056763 · Cited by 43
Pancreatic islet autoimmunity
Boîtard, C. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.10.003 · Cited by 48
Toward beta cell replacement for diabetes
Jóhannesson, B., Sui, L., Freytes, D. O., Creusot, R. J., & Egli, D. M. (2015) · The EMBO Journal · doi:10.15252/embj.201490685 · Cited by 47
Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells
Singh, Y., Chen, H., Zhou, Y., Föller, M., Mak, T. W., Salker, M. S., & Lang, F. J. W. (2015) · Scientific Reports · doi:10.1038/srep17723 · Cited by 45
Genomic structure of the horse major histocompatibility complex class II region resolved using PacBio long-read sequencing technology
Viļuma, A., Mikko, S., Hahn, D., Skow, L. C., Andersson, G., & Bergström, T. F. (2017) · Scientific Reports · doi:10.1038/srep45518 · Cited by 48
Closed-loop insulin delivery: update on the state of the field and emerging technologies
Ware, J., & Hovorka, R. (2022) · Expert Review of Medical Devices · doi:10.1080/17434440.2022.2142556 · Cited by 47
Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
Ssekamatte, P., Sande, O. J., van Crevel, R., & Biraro, I. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122255 · Cited by 52
Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin
Ashton, M. P., Eugster, A., Walther, D., Daehling, N., Riethausen, S., Kuehn, D., Klingel, K., Beyerlein, A., Zillmer, S., Ziegler, A., et al. (2016) · Scientific Reports · doi:10.1038/srep32899 · Cited by 43
Immunology of β-Cell Destruction
Torre, D. L., & Lernmark, Å. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_24 · Cited by 43
Ambient air pollution and incidence of early-onset paediatric type 1 diabetes: A retrospective population-based cohort study
Elten, M., Donelle, J., Lima, I. S. F., Burnett, R. T., Weichenthal, S., Stieb, D. M., Hystad, P., van Donkelaar, A., Chen, H., Paul, L. A., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109291 · Cited by 42
Type 1 diabetes and associated autoimmune diseases
Frommer, L., & Kahaly, G. J. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i11.527 · Cited by 41
A review of risk factors associated with insulin omission for weight loss in type 1 diabetes
Hall, R., Keeble, L., Sünram‐Lea, S. I., & To, M. P. S. (2021) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045211026142 · Cited by 51
A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children
Endesfelder, D., Hagen, M., Winkler, C., Haupt, F., Zillmer, S., Knopff, A., Bonifacio, E. E., Ziegler, A., zu Castell, W., & Achenbach, P. (2016) · Diabetologia · doi:10.1007/s00125-016-4050-0 · Cited by 43
Targeting Memory T Cells in Type 1 Diabetes
Ehlers, M. R., & Rigby, M. R. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0659-5 · Cited by 40
A20 as an immune tolerance factor can determine islet transplant outcomes
Zammit, N. W., Walters, S. N., Seeberger, K. L., O’Connell, P. J., Korbutt, G. S., & Grey, S. T. (2019) · JCI Insight · doi:10.1172/jci.insight.131028 · Cited by 38
Body Image Problems and Disordered Eating Behaviors in Italian Adolescents With and Without Type 1 Diabetes: An Examination With a Gender-Specific Body Image Measure
Troncone, A., Cascella, C., Chianese, A., Zanfardino, A., Piscopo, A., Borriello, A., Casaburo, F., del Giudice, E. M., & Iafusco, D. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.556520 · Cited by 40
Epigenetic Mechanisms of Metabolic Memory in Diabetes
Jayaraman, S. (2012) · Circulation Research · doi:10.1161/circresaha.112.268375 · Cited by 38
Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes
Marroquí, L., Perez-Serna, A. A., Babiloni-Chust, I., & dos Santos, R. S. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.011 · Cited by 37
Enhancing Type 1 Diabetes Immunological Risk Prediction with Continuous Glucose Monitoring and Genetic Profiling
Montaser, E., Farhy, L. S., & Rich, S. S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0496 · Cited by 39
Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammation
Evangelista, A. F., Collares, C. V. A., Xavier, D. J., Macedo, C., Manoel-Caetano, F. S., Rassi, D. M., Foss‐Freitas, M. C., Foss, M. C., Sakamoto‐Hojo, E. T., Nguyen, C., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-28 · Cited by 36
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes
Zhang, J., Hamey, F., Trzupek, D., Mickunas, M., Lee, M., Godfrey, L., Yang, J. H. M., Pękalski, M. Ł., Kennet, J., Waldron-Lynch, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34162-3 · Cited by 40
Self-citation
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice
Conte, M. L., Cencicchio, M. A., Ulaszewska, M., Nobili, A., Cosorich, I., Ferrarese, R., Massimino, L., Andolfo, A., Ungaro, F., Mancini, N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1089987 · Cited by 38
No association between type 1 diabetes and genetic variation in vitamin D metabolism genes: a Danish study
Thorsen, S. U., Mortensen, H. B., Carstensen, B., Fenger, M., Thuesen, B. H., Husemoen, L. L. N., Bergholdt, R., Brorsson, C., Pociot, F., Linneberg, A. R., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12105 · Cited by 35
Gene-environment interaction in chronic disease: A European Science Foundation Forward Look
Renz, H., Autenrieth, I. B., Brandtzæg, P., Cookson, W., Holgate, S. T., von Mutius, E., Valenta, R., & Haller, D. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.039 · Cited by 35
Inferior alveolar nerve transection disturbs innate immune responses and bone healing after tooth extraction
Xu, Y., Xia, M., Chen, T., Yang, Y., Fu, G., Ji, P., & Wu, Q. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14120 · Cited by 37
Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease?
la Marca, G., Malvagia, S., Toni, S., Piccini, B., Ciommo, V. M. D., & Bottazzo, G. F. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.33 · Cited by 34
Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment
Hotta-Iwamura, C., & Tarbell, K. V. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr1115-500r · Cited by 37
Type 1 diabetes: genes associated with disease development
Klak, M., Gomółka, M., Kowalska, P. D., Cichoń-Woźniak, J., Ambrożkiewicz, F., Serwańska-Świętek, M., Berman, A., & Wszola, M. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2020.103386 · Cited by 39
Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
Pham, M. N., von Herrath, M. G., & Vela, J. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00651 · Cited by 34
Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes
Prasad, S., Xu, D., & Miller, S. D. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.319 · Cited by 35
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
Lee, J. S., Scandiuzzi, L., Ray, A., Wei, J., Hofmeyer, K. A., Abadi, Y. M., Loke, P., Lin, J., Yuan, J. D., SERREZE, D. V., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201241 · Cited by 34
Genome-wide association studies and systems biology: together at last
Ala‐Korpela, M., Kangas, A. J., & Inouye, M. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.09.002 · Cited by 33
Analysis of the HLA and non‐HLA susceptibility loci in Japanese type 1 diabetes
Yamashita, H., Awata, T., Kawasaki, E., Ikegami, H., Tanaka, S. A., Maruyama, T., Shimada, A., Nakanishi, K., Takahashi, K., Kobayashi, T., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1234 · Cited by 33
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
Waldron-Lynch, F., Kareclas, P., Kathryn, I., Walker, N. M., Mander, A., Wicker, L. S., Todd, J. A., & Bond, S. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005559 · Cited by 31
Self-citation
Evidence that Cd101 Is an Autoimmune Diabetes Gene in Nonobese Diabetic Mice
Rainbow, D. B., Moule, C. L., Fraser, H. I., Clark, J., Howlett, S., Burren, O. S., Christensen, M. B., Moody, V., Steward, C. A., Mohammed, J. P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003523 · Cited by 33
Self-citation
A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion
Bonifacio, E. E., Krumsiek, J., Winkler, C., Theis, F. J., & Ziegler, A. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0526-2 · Cited by 32
Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
Fox, L. E., Locke, M. C., & Lenschow, D. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606874 · Cited by 36
Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes.
Manan, H., Angham, A., & Sitelbanat, A. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.09.008 · Cited by 37
Down Syndrome and Autoimmune Disease
Hom, B. M., Boyd, N. K., Vogel, B. N., Nishimori, N. A., Khoshnood, M. M., Jafarpour, S., Nagesh, D., & Santoro, J. D. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08996-2 · Cited by 39
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
Christen, U., & von Herrath, M. G. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.71 · Cited by 31
The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles
Ortiz, G. G. R., Zaidi, N. H., Saini, R. S., Ramírez‐Coronel, A. A., Alsandook, T., Lafta, M. H., Arias‐Gonzáles, J. L., Amin, A. H., & Maaliw, R. R., III (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110531 · Cited by 31
Evidence of association with type 1 diabetes in the SLC11A1 gene region
Yang, J. H. M., Downes, K., Howson, J. M. M., Nutland, S. L., Stevens, H. E., Walker, N. M., & Todd, J. A. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-59 · Cited by 34
Self-citation
Celiac Disease and Endocrine Autoimmunity
Kahaly, G. J., & Schuppan, D. (2015) · Digestive Diseases · doi:10.1159/000369535 · Cited by 31
LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice
Chen, J., Hu, Y., Chen, Y., Zhou, Z., Shen, Y., Wang, Y., Liu, Z., Li, X., Su, Z., & Wu, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.020 · Cited by 30
Mechanistic basis of immunotherapies for type 1 diabetes mellitus
Chen, W., Xie, A., & Chan, L. (2013) · Translational research · doi:10.1016/j.trsl.2012.12.017 · Cited by 32
Healthy First‐Degree Relatives of Patients with Type 1 Diabetes Exhibit Significant Differences in Basal Gene Expression Pattern of Immunocompetent Cells Compared to Controls: Expression Pattern as Predeterminant of Autoimmune Diabetes
Štechová, K., Kolář, M., Blatný, R., Halbhuber, Z., Včeláková, J., Hubackova, M., Petruželková, L., Šumnı́k, Z., Obermannová, B., Piťhová, P., et al. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02637.x · Cited by 29
HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA‐DRB1*03 haplotype
Howson, J. M. M., Roy, M. S., Zeitels, L. R., Stevens, H. E., & Todd, J. A. (2013) · Diabetic Medicine · doi:10.1111/dme.12148 · Cited by 31
Self-citation
Transcriptome Analysis of Epigenetically Modulated Genome Indicates Signature Genes in Manifestation of Type 1 Diabetes and Its Prevention in NOD Mice
Jayaraman, S., Patel, A., Jayaraman, A. K., Patel, V., Holterman, M., & Prabhakar, B. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055074 · Cited by 29
The microbiology of human hygiene and its impact on type 1 diabetes
Chapman, N. M., Coppieters, K. T., von Herrath, M., & Tracy, S. (2012) · Islets · doi:10.4161/isl.21570 · Cited by 31
Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells
Valta, M., Gazali, A. M., Viisanen, T., Ihantola, E., Ekman, I., Toppari, J., Knip, M., Veijola, R., Ilonen, J., Lempainen, J., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948378 · Cited by 34
Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase
Neuwirth, A., Dobeš, J., Oujezdská, J., Ballek, O., Benešová, M., Šumnı́k, Z., Včeláková, J., Koloušková, S., Obermannová, B., Kolář, M., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2011.12.001 · Cited by 28
Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFF
Parsons, R. F., Yu, M., Vivek, K., Quinn, G. Z., Rostami, S. Y., Ziaie, A. S., Luo, Y., Koeberlein, B., Redfield, R. R., Ward, C. D. W., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318246621d · Cited by 28
On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota
Gianchecchi, E., & Fierabracci, A. (2016) · Immunologic Research · doi:10.1007/s12026-016-8832-8 · Cited by 29
Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes
Azhir, Z., Dehghanian, F., & Hojati, Z. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4352-z · Cited by 27
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
Marcovecchio, M. L., Wicker, L. S., Dunger, D. B., Dutton, S., Kopijasz, S., Scudder, C. L., Todd, J. A., & Johnson, P. R. V. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15697.1 · Cited by 26
Self-citation
The Sardinian Way to Type 1 Diabetes
Songini, M., & Lombardo, C. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400526 · Cited by 27
HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients
Mbunwe, E., der Auwera, B. J. R. V., Vermeulen, I., Demeester, S., Dalem, A. V., Balti, E. V., Aken, S. V., Derdelinckx, L., Dorchy, H., Schepper, J. D., et al. (2012) · Diabetes · doi:10.2337/db12-0747 · Cited by 27
Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort
Garnier, L., Marchand, L., Benoit, M., Nicolino, M. P., Bendelac, N., Wright, C. C., Moulin, P., Lombard, C., Thivolet, C. H., & Fabien, N. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.043 · Cited by 26
Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach
Jafar, A., Fathi, A. E., & Haidar, A. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.105936 · Cited by 27
Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes
Jörns, A., Akin, M., Arndt, T., Terbish, T., zu Vilsendorf, A. M., Wedekind, D., Hedrich, H.-J., & Lenzen, S. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1137-2 · Cited by 26
Islet transplantation-immunological challenges and current perspectives
Kabakchieva, P., Assyov, Y. S., Gerasoudis, S., Vasilev, G., Peshevska-Sekulovska, M., Sekulovski, M., Lazova, S., Miteva, D., Gulinac, M., Tomov, L., et al. (2023) · World Journal of Transplantation · doi:10.5500/wjt.v13.i4.107 · Cited by 30
The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis
Ramos-Rodríguez, M., Pérez-González, B., & Pasquali, L. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01370-4 · Cited by 26
Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris
Koga, H., Tsuruta, D., Ohyama, B., Ishii, N., Hamada, T., Ohata, C., Furumura, M., & Hashimoto, T. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.744823 · Cited by 25

Authors: Todd, J. A.
Affiliations: University of Cambridge (GB)
Corresponding author: Todd, John A.
ORCID: Todd, John A.
Venue: Immunity
Publisher: Elsevier BV
Published: 2010-04
Volume: 32
Issue: 4
Pages: 457-467
ISSN: 1074-7613 (ISSN-L)
DOI: 10.1016/j.immuni.2010.04.001
OpenAlex: W1997112242
Cited by: 560
References: 120
Citations by year: 2026: 12 · 2025: 19 · 2024: 30 · 2023: 32 · 2022: 28 · 2021: 32 · 2020: 35 · 2019: 29 · 2018: 25 · 2017: 22 · 2016: 47 · 2015: 49 · 2014: 45 · 2013: 38 · 2012: 59
FWCI: 5.25
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1239 d)
Locations: Immunity (publishedVersion)
PubMed (publishedVersion)
Funders: Wellcome Trust (061858)
National Institute for Health and Care Research (NF-SI-0508-10275)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: type 1 diabetes, genetic etiology, HLA class II, HLA class I, T cell receptor, T cell activation, B cell activation, innate immune response, viral infection, chemokine signaling, cytokine signaling, regulatory T cells, antigen-presenting cells, epigenetic factors, environmental factors, disease susceptibility, gene mapping, genotype-phenotype correlation
MeSH terms: Animals, Diabetes Mellitus, Type 1, Gene Expression Regulation, Humans, Phenotype, Genetic Predisposition to Disease, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Etiology of Type 1 Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks